ELDN Eledon Pharmaceuticals
- 2.300
- +0.010+0.44%
- 2.360
- +0.060+2.61%
Eledon Pharmaceuticals所有资讯
Eledon Pharmaceuticals | 10-K/A：年度报表(修正版)
Eledon Pharmaceuticals | 10-K：年度报表
Eledon Pharmaceuticals | 8-K：Eledon Pharmicals公布2023年第四季度和全年运营和财务业绩
Eledon Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Eledon Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
Eledon Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-BVF Partners L.P.(17.9%),BVF Inc.(17.9%)等
Eledon Pharmaceuticals：2023财年三季报
Eledon Pharmaceuticals | 8-K：Eledon Pharmicals公布2023年第三季度经营和财务业绩
Eledon Pharmaceuticals | 8-K：重大事件
Eledon Pharmaceuticals | 4：持股变动声明-董事 Robinson James A. Jr.
Eledon Pharmaceuticals | 4：持股变动声明-董事 Kirk Allan
Eledon Pharmaceuticals | 3：首次持股声明-董事 Robinson James A. Jr.
Eledon Pharmaceuticals | 3：首次持股声明-董事 Kirk Allan
Eledon Pharmaceuticals | 8-K：重大事件
Eledon Pharmaceuticals | 8-K：重大事件
Eledon Pharmaceuticals | 8-K：重大事件
Eledon Pharmaceuticals | S-8：员工福利计划证券登记
Eledon Pharmaceuticals | 10-Q：2023财年二季报
Eledon Pharmaceuticals | 8-K：Eledon Pharmicals 公布了 2023 年第二季度运营和财务业绩
Eledon Pharmaceuticals | 8-K：重大事件
分析
目标价预测
暂无数据
